Works matching IS 14741776 AND DT 2002 AND VI 1 AND IP 9
Results: 20
Clinical proteomics: translating benchside promise into bedside reality.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 683, doi. 10.1038/nrd891
- By:
- Publication type:
- Article
Opinion: The druggable genome.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 727, doi. 10.1038/nrd892
- By:
- Publication type:
- Article
Phosphodiesterase 5 inhibitors: current status and potential applications.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 674, doi. 10.1038/nrd893
- By:
- Publication type:
- Article
ATPases as drug targets: learning from their structure.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 665, doi. 10.1038/nrd894
- By:
- Publication type:
- Article
Protein tyrosine phosphatase 1B inhibitors for diabetes.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 696, doi. 10.1038/nrd895
- By:
- Publication type:
- Article
Opinion: Drug addictions: towards socially accepted and medically treatable diseases.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 731, doi. 10.1038/nrd896
- By:
- Publication type:
- Article
Pharmacotherapy of addictions.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 710, doi. 10.1038/nrd897
- By:
- Publication type:
- Article
From the analyst's couch: Erectile-dysfunction therapies.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 663, doi. 10.1038/nrd898
- By:
- Publication type:
- Article
HIV: Vif ? a new therapeutic target?
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 658, doi. 10.1038/nrd899
- By:
- Publication type:
- Article
Drug delivery: Engineering a smoother ride.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 658, doi. 10.1038/nrd900
- By:
- Publication type:
- Article
Anticancer drugs: Pulling the plug on cancer.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 657, doi. 10.1038/nrd901
- By:
- Publication type:
- Article
Obesity: Adipocyte metabolism.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 661, doi. 10.1038/nrd902
- By:
- Publication type:
- Article
High-throughput screening: Lighting up targets with reporter ribozymes.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 659, doi. 10.1038/nrd903
- By:
- Publication type:
- Article
Target validation: Target for the modern-day ills?
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 661, doi. 10.1038/nrd904
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 661, doi. 10.1038/nrd905
- Publication type:
- Article
Learning and memory: Weeding out memory extinction.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 662, doi. 10.1038/nrd906
- By:
- Publication type:
- Article
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 662
- Publication type:
- Article
Emerging unscathed?
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 739, doi. 10.1038/nrd910
- By:
- Publication type:
- Article
The prince and the pauper.
- Published in:
- 2002
- Publication type:
- Editorial
Antipsychotics: How Goldilocks is partial to dopamine receptors.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 660, doi. 10.1038/nrd912
- By:
- Publication type:
- Article